A patient with a deficiency of dihydrolipoyl dehydrogenase and neurological disease is described. The patients was placed on a branched-chain amino acid-restricted regimen. After the introduction of the regimen, there were some biochemical improvements and he achieved some developmental milestones, in contrast to previously reported patients whose neurological disease was progressive. Restriction of the branched-chain amino acids is worth trying among therapeutic measures for this disease, although restriction of the amino acids alone may not totally prevent progression of neurological disease.
This is a preview of subscription content, log in to check access.
Buy single article
Instant access to the full article PDF.
Price includes VAT for USA
Subscribe to journal
Immediate online access to all issues from 2019. Subscription will auto renew annually.
This is the net price. Taxes to be calculated in checkout.
Blass JP, Avigan J, Uhlendorf BW (1970) A defect in pyruvate decarboxylase in a child with an intermittent movement disorder. J Clin Invest 49:423–432
Blass JP, Schulman JD, Young DS, Hom E (1972) An inherited defect affecting the tricarboxylic acid cycle in a patient with congenital lactic acidosis. J Clin Invest 51:1845–1851
Hayashi T, Tsuchiya H, Todoriki H, Naruse H (1982) High-performance liquid chromatographic determination of α-ketoacids in human urine and plasma. Anal Biochem 122:173–179
Kornberg A (1955) Lactate dehydrogenase of muscle. Methods Enzymol 1:441–443
Kuhara T, Shinka T, Inoue Y, Matsumoto M, Yoshino M, Sakaguchi Y, Matsumoto I (1983) Studies of organic acid profiles of a patient with dihydrolipoyl dehydrogenase deficiency. Clin Chim Acta 133:133–140
Matalon R, Stumpf DA, Kimberlee M, Hart RD, Parks JK, Goodman RI (1984) Lipoamide dehydrogenase deficiency with primary lactic acidosis: favourable response to treatment with oral lipoic acid. J Pediatr 104:65–69
Munnich A, Saudubray JM, Taylor J, Charpentier C, Marsac C, Rocchiccioli F, Amedee-Manesme O, Coude FX, Frezal J, Robinson BH (1982) Congenital lactic acidosis, α-ketoglutaric aciduria and variant form of maple syrup urine disease due to a single enzyme defect: dihydrolipoyl dehydrogenase deficiency. Acta Paediatr Scand 71:167–171
Reed LJ, Willms CR (1966) Purification and resolution of the pyruvate dehydrogenase complex (Escherichia coli). Methods Enzymol 9:247–265
Robinson BH, Taylor J, Sherwood WG (1977) Deficiency of dihydrolipoyl dehydrogenase (a component of the pyruvate and α-ketoglutarate dehydrogenase complexes): a cause of congenital chronic lactic acidosis in infancy. Pediatr Res 11:1198–1202
Robinson BH, Taylor J, Kahler SG, Kirkman HN (1981) Lactic acidemia, neurological deterioration and carbohydrate dependence in a girl with dihydrolipoyl dehydrogenase deficiency. Eur J Pediatr 136:35–39
Tabor J, Tabor H, Rosenthal SM (1954) Purification of amine oxidase from beef plasma. J Biol Chem 208:645–661
Tanaka K, Rosenberg LE (1982) Disorders of branched chain amino acid and organic acid metabolism. In: Stanbury JB, Wyngaarden JB, Fredrichsen DS, Goldstein JL, Brown MS (eds) The metabolic basis of inherited disease. McGraw-Hill, New York, pp 440–473
Taylor J, Robinson BH, Sherwood WG (1978) A defect in branched-chain amino acid metabolism in a patient with congenital lactic acidosis due to dihydrolipoyl dehydrogenase deficiency. Pediatr Res 12:60–62
Wharton DC, Tzagoloff A (1967) Cytochrome oxidase from beef heart mitochondria. Methods Enzymol 10:245–250
About this article
Cite this article
Sakaguchi, Y., Yoshino, M., Aramaki, S. et al. Dihydrolipoyl dehydrogenase deficiency: a therapeutic trial with branched-chain amino acid restriction. Eur J Pediatr 145, 271–274 (1986). https://doi.org/10.1007/BF00439399
- Dihydrolipoyl dehydrogenase
- Branched-chain amino acids
- Restricted diet